Gastrointestinal Endoscopy Articles & Analysis
17 news found
” WATS3D technology helps clinicians overcome the limitations associated with traditional upper endoscopy screening and surveillance methods, by combining a specially designed brush, unique 3D imaging powered by AI, and a team of trained GI pathologists. ...
VE202 was also well tolerated, with most adverse events unrelated to study treatment, gastrointestinal in nature, and of mild or moderate intensity. About Vedanta Biosciences Vedanta Biosciences is leading the development of a potential new category of oral therapies based on defined consortia of bacteria isolated from the human microbiome and grown from pure clonal cell banks. ...
WATS3D technology helps clinicians to overcome the limitations associated with traditional upper endoscopy screening and surveillance methods, by combining a specially designed brush, unique 3D imaging powered by artificial intelligence, and a team of trained GI pathologists. ...
The gold standard in the diagnosis of IBD is gastrointestinal endoscopy with additional biopsy. However, this is an invasive and also cost-intensive examination. ...
Data from Pooled-Analysis of Enteral Protease Inhibitor LB1148 Demonstrated 72% Reduction in the Risk of Adhesion Formation in Patients Undergoing Bowel Resection Surgery Company to Host Conference Call on Wednesday, March 16, 2022, at 8:30 a.m. EST Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) ...
Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, was selected to present an ePoster entitled “Pooled-Analysis of Incidence and Severity of Post-Surgical Intraabdominal Adhesions following Bowel Resection Surgery and Treatment with Enteral Protease Inhibitor LB1148” at The Next ...
Medical device and technology company Lazurite Holdings LLC today announced a new phase of collaboration with University Hospitals (UH) Ventures, the innovation and commercialization arm of University Hospitals Health System in Cleveland, which will include an investment from UH Ventures. The amount and details of the investment were not specified. This past August, Lazurite announced its ...
A newly published study as lead article in Gastrointestinal Endoscopy shows that Barrett’s esophagus (BE) and dysplasia progress to esophageal cancer at similar, or even higher, rates when diagnosed by WATS3D (wide-area transepithelial sampling with three-dimensional analysis) as they do when diagnosed by conventional forceps biopsies. ...
This past summer, the ArthroFree system won the prestigious inaugural ACE Award for Innovation at the annual meeting of the American Orthopaedic Society for Sports Medicine and was one of three finalists in the Shark Tank competition at the annual meeting of the Society of American Gastrointestinal and Endoscopic Surgeons. In December, MedTech Outlook magazine named Lazurite a ...
Medical device and technology company Lazurite Holdings LLC has been recognized by MedTech Outlook magazine as a 2021 Top 10 Endoscopy Device Provider for its ArthroFree™ wireless camera system for minimally invasive surgery. MedTech Outlook describes itself as a platform that bridges the spectrum between medtech technology providers and healthcare facilities and medical ...
” WATS3D technology helps clinicians to overcome the limitations associated with traditional upper endoscopy screening and surveillance methods, by combining a specially designed brush, unique 3D imaging powered by artificial intelligence, and a team of trained GI pathologists. ...
Sanford, Florida (July 28, 2021) — Omega Medical Imaging, the leading innovator in AI image-guided interventional systems for hospitals and healthcare facilities around the world, announced the installation of the E-View.AI interventional endoscopy system at the Pali Momi Medical Center in Hawai’i. The E-View.AI represents the first AI image-guided system in the state ...
In this study, we found that combining one-time Revita DMR treatment with GLP-1RA medication could successfully eliminate insulin therapy for a majority of patients, whereas earlier studies of a GLP-1RA medication alone have not been able to demonstrate such findings[1],” said Jacques Bergman, M.D., Ph.D., a professor of gastrointestinal endoscopy at ...
MENLO PARK, California, October 9, 2020 — Galaxy Medical, (Galaxy), a developer of Pulsed Electric Field (PEF) technology for the treatment of cardiac arrhythmias, today announced that the first patients were successfully treated with the proprietary CENTAURI™ System by Dr. Ante Ani in Split, Croatia as part of the ECLIPSE-AF study. This multicenter trial is designed to assess the ...
” EPI will utilize its established distribution network along with new strategic partners to bring this innovative product to the GI Endoscopy market. EndoClot Plus is focused on utilizing its polymer expertise to develop customized medical devices to meet GI clinical needs. ...
The article, entitled “Impact of EUS-guided microforceps biopsy and needle-based confocal laser endomicroscopy on the diagnostic yield and clinical management of pancreatic cystic lesions” was published in Gastrointestinal Endoscopy (2019, DOI: 10.1016/j.gie.2019.12.022). The article was authored by the team of physicians that conducted the study, ...
With its innovative vision and technology, EndoClot Plus aims to become the leading company in creating new biomaterial therapeutic solutions for GI Endoscopy. About EndoClot Plus Inc. EndoClot Plus, Inc. (EPI) is a privately owned company in Santa Clara, California. In collaboration with surgeons and biomaterial scientists, EPI developed a breakthrough technology to control ...